CVS Health Co. (NYSE:CVS) Shares Sold by Oxford Financial Group LTD. LLC

Oxford Financial Group LTD. LLC reduced its position in CVS Health Co. (NYSE:CVS) by 8.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,302 shares of the pharmacy operator’s stock after selling 309 shares during the period. Oxford Financial Group LTD. LLC’s holdings in CVS Health were worth $263,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Atticus Wealth Management LLC lifted its position in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. USA Financial Formulas lifted its position in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in CVS Health during the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC acquired a new position in CVS Health during the 4th quarter worth approximately $34,000. Finally, Steph & Co. lifted its position in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS traded up $0.57 during trading on Wednesday, reaching $58.54. 7,622,615 shares of the company were exchanged, compared to its average volume of 11,595,431. The stock has a market cap of $73.49 billion, a P/E ratio of 10.29, a PEG ratio of 0.56 and a beta of 0.52. The firm has a 50 day moving average of $58.76 and a 200 day moving average of $67.67. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.20 earnings per share. On average, sell-side analysts forecast that CVS Health Co. will post 7.01 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.54%. CVS Health’s payout ratio is 46.75%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CVS shares. Cantor Fitzgerald reissued a “neutral” rating and set a $58.00 price target on shares of CVS Health in a research report on Tuesday. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. Bank of America cut their target price on CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Truist Financial reaffirmed a “buy” rating and issued a $66.00 target price (down from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Finally, TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and cut their target price for the company from $99.00 to $59.00 in a research report on Tuesday, May 7th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

Insider Transactions at CVS Health

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.